Independent report

JCVI update on advice for COVID-19 vaccination of children aged 5 to 11

Statement from the Joint Committee on Vaccination and Immunisation on vaccinating children aged 5 to 11.

Documents

Details

JCVI advises a non-urgent offer of two 10 mcg doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) to children aged 5 to 11 years of age who are not in a clinical risk group.

The intention of this offer is to increase the immunity of vaccinated individuals against severe COVID-19 in advance of a potential future wave of COVID-19.

Published 16 February 2022